Factory Price High Purity 99.0% Pasireotide raw peptide powder CAS NO.:96091-73-9 Research Chemical Appearance White powder
Purity (HPLC) ≥95.0%
Acetate content 5.0%~12.0%
Moisture content≤8.0%
Peptide content ≥ 80.0%
Packaging and Shipping:
Low temperature, vacuum packaging, accurate to milligrams upon request.
Product Description:
Pasireotide is a somatostatin analog with a cyclic hexapeptide structure. Pasireotide, as the main component of the drug, is suitable for the treatment of adult patients with Cushing's disease who have not undergone pituitary surgery or have not been cured by surgery. Compared with octreotide, pasiiretide has a longer half-life, can bind to more receptors, inhibit pancreatic secretion, inhibit the activity of intestinal proteolytic enzymes, and reduce postoperative complications of pancreas through these mechanisms.
Storage method: Freeze-dry at -20°C and store in the dark
Remarks: For research only, not for human use
Factory Price High Purity 99.0% Pasireotide raw peptide powder CAS NO.:96091-73-9 Research Chemical Appearance White powder
Purity (HPLC) ≥95.0%
Acetate content 5.0%~12.0%
Moisture content≤8.0%
Peptide content ≥ 80.0%
Packaging and Shipping:
Low temperature, vacuum packaging, accurate to milligrams upon request.
Product Description:
Pasireotide is a somatostatin analog with a cyclic hexapeptide structure. Pasireotide, as the main component of the drug, is suitable for the treatment of adult patients with Cushing's disease who have not undergone pituitary surgery or have not been cured by surgery. Compared with octreotide, pasiiretide has a longer half-life, can bind to more receptors, inhibit pancreatic secretion, inhibit the activity of intestinal proteolytic enzymes, and reduce postoperative complications of pancreas through these mechanisms.
Storage method: Freeze-dry at -20°C and store in the dark
Audited Supplier 
){kind=link}